Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Updates on ensuing Board Meeting on May 13, 2016

 With reference to the earlier letter dated April 25, 2016, Cadila Healthcare Ltd has now informed BSE that the Board of Directors [the Board] at its meeting to be held on May 13, 2016, will also consider the following proposals for raising funds / issuance of securities, which will be subject to approval of the members:1. to raise funds by issue of Equity Shares / convertible Bonds / Debentures through Qualified Institutional Placement [QIP]...
30-04-2016
Bigul

FY16 results on May 13, 2016

 Cadila Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 13, 2016, inter alia, to consider & approve the audited financial results for the year ended on March 31, 2016.Further, as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will remain closed from May 02, 2016 to May 15,...
25-04-2016
Bigul

Deepak Parekh, Pawan Munjal on shortlist for next IIM-A chairman

 Pankaj Patel, CMD, Cadila Healthcare to be interim chairman until successor to A M Naik finalised
20-04-2016
Bigul

Shareholding for the Period Ended March 31, 2016

 Cadila Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here
08-04-2016
Bigul

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016

 Cadila Healthcare Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
06-04-2016
Bigul

Zydus Cadila gets final nod from USFDA for Carboplatin injection

 Cadila Healthcare (Zydus Cadila) on Friday informed that the company has recieved the final approval from the US drug regulator, USFDA to market Carboplatin Injection, 10 mg/ml in 5 ml, 15 ml and 45 ...
01-04-2016
Bigul

Zydus receives final approval from the USFDA for Carboplatin Injection

 Cadila Healthcare Ltd has informed BSE regarding a Press Release dated April 01, 2016 titled "Zydus receives final approval from the USFDA for Carboplatin Injection".
01-04-2016
Bigul

Gujarat State TB Association, Sparsh and Cadila Pharma organise medical camps

 Awareness was raised on tuberculosis where more than 300 villagers underwent health checkups and were given consultations
31-03-2016
Bigul

Zydus Nesher Pharmaceuticals receives its first ANDA approval for Dextroamphetamine IR Tabs

 Cadila Healthcare Ltd has informed BSE regarding a Press Release dated March 30, 2016 titled "Zydus Nesher Pharmaceuticals receives its first ANDA approval for Dextroamphetamine IR Tabs".
30-03-2016
Bigul

Zydus Cadila gets USFDA nod to market Acyclovir capsules

 The group now has more than 100 approvals
29-03-2016
Next Page
Close

Let's Open Free Demat Account